Article Details

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B

Retrieved on: 2021-07-22 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B. View article details on HISWAI: https://www.geekwire.com/2021/absci-shares-spike-30-ipo-debut-valuing-washington-state-biotech-company-nearly-2b/

Excerpt

... including Merck, and through the recent acquisition of synthetic biology company Totient and Denovium, a small deep learning startup that analyzes ...

Article found on: www.geekwire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up